Healthcare & Life Sciences

Eye lubricant patent application US20260083588A1 by Meibomian Solutions LLC

Eye lubricant patent application US20260083588A1 by Meibomian Solutions LLC

USPTO Patent Application for Absorbent Article Packages

The USPTO has published a new patent application (US20260083599A1) for absorbent article packages. The application, filed on September 17, 2025, describes a cuboidal package design with reclosable features for one or more absorbent articles.

Ophthalmic Surgical Instrument Patent Application

The USPTO has published a patent application (US20260083590A1) for an ophthalmic surgical instrument designed for improved capsular bag safety and efficiency in phacoemulsification and irrigation/aspiration procedures. The application details specific tip designs with convexly curved side walls and flat bottom walls.

Configurable Absorbent Articles Patent Application

The USPTO has published a patent application (US20260083601A1) for configurable absorbent articles featuring removable fastening members. The application details the inventors and the technical abstract describing the article's components, including a topsheet, backsheet, absorbent core, leg cuffs, and fastening members. The filing date was August 20, 2025.

Suture/Anchor and Delivery Device Combination Patent Application

The USPTO has published a new patent application (US20260083448A1) for a suture/anchor and delivery device combination. The application, filed on September 20, 2023, describes a device designed for interference fixation within bone using a novel suture assemblage and inserter.

Patent Application for Implant Compositions for Tendon Repair

The USPTO has published a new patent application (US20260083879A1) for implant compositions and methods for tendon and ligament repair. The application describes a composition of fibers and osteoinductive material to enhance bone formation and provide initial fixation for tendon to bone repair.

Tampon with wicking member and improved manufacturability patent application

The USPTO has published a new patent application (US20260083597A1) for a tampon with a wicking member and improved manufacturability. The application details an invention involving a non-coaxially arranged wicking member with respect to the withdrawal cord.

Malleable Earplug Attachment for Safety Glasses

The USPTO has published a patent application (US20260083593A1) for a malleable earplug attachment designed for safety glasses. The attachment includes an earplug, an elastic band, and a pocket to secure it to the temple ends of standard safety glasses.

USPTO Patent Application for Bioimplant Alloy

The USPTO has published patent application US20260085389A1 for a novel high entropy alloy developed by KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS. The alloy is intended for bioimplant applications and is designed to offer improved corrosion resistance, anti-bacterial properties, and a reduced elastic modulus.

Eye Shunt System and Methods Patent Application

The USPTO has published a new patent application, US20260083592A1, for an eye shunt system and methods. The application details a device designed to regulate intraocular pressure by receiving aqueous fluid from the eye and releasing it to the sclera.

Patent Application: Methods for treating epilepsy using 5HT receptor agonists

The USPTO has published a new patent application (US20260083706A1) detailing methods for treating epilepsy using 5HT receptor agonists. The application was filed on May 29, 2025, by inventor Scott C. Baraban.

Novel LXR Modulators with Bicyclic Core for Treating Dyslipidemias

The USPTO has published a new patent application, US20260083704A1, detailing novel LXR modulators with a bicyclic core for treating dyslipidemias and related metabolic disorders. The application was filed on May 1, 2025, and published on March 26, 2026.

USPTO Patent Application for Transdermal Dexmedetomidine

The USPTO has published patent application US20260083705A1 for methods of using transdermal delivery patches containing dexmedetomidine to treat agitation. The application was filed on September 24, 2025, by inventors Wan-Ning Song and Gary G. Kay.

Multilayered Microparticles for Controlled Release of Active Compounds

The USPTO has published a new patent application (US20260083713A1) detailing multilayered microparticles for controlled release of active compounds in liquid dosage forms. The application was filed on October 21, 2025, by inventors from Belgium.

Patent Application: Compounds for Inhibiting IL-17

The USPTO has published a patent application (US20260083708A1) detailing compounds for inhibiting IL-17 activity. The application, filed on December 1, 2025, describes compounds and methods for treating inflammatory and autoimmune disorders.

Patent for treating ocular autoimmune disorder comorbidities with roflumilast

The USPTO has published a new patent application (US20260083712A1) assigned to Iolyx Therapeutics, Inc. The patent describes methods for treating ocular comorbidities of autoimmune disorders, such as dry eye disease, using ophthalmic formulations of roflumilast. The application was filed on September 19, 2025.

Tinostamustine for T-cell prolymphocytic leukemia treatment patent

The USPTO has published a patent application (US20260083707A1) for Purdue Pharma L.P. detailing the use of tinostamustine for treating T-cell prolymphocytic leukemia. The application was filed on July 28, 2025.

USPTO Patent Application for Acute Migraine Treatment with Ubrogepant

The USPTO has published a new patent application (US20260083710A1) detailing methods for the acute treatment of migraine using the drug ubrogepant. The application includes specific claims related to treatment in patients with hepatic or renal impairment and those concurrently taking certain CYP3A4 modulators or BCRP/P-gp inhibitors.

Patent Application: Combination Pharmacological Interventions for Sleep Apnea

The USPTO has published patent application US20260083709A1, detailing a novel pharmacological intervention for treating obstructive sleep apnea. The application, filed on December 3, 2025, describes pharmaceutical compositions involving a combination of a norepinephrine reuptake inhibitor, muscarinic receptor antagonist, and carbonic anhydrase inhibitor.

NY Landmarks Lit Purple for International Epilepsy Day

The New York State Department of Health announced that 16 state landmarks were lit purple on March 26, 2026, for International Epilepsy Day. This initiative honors the estimated 215,000 New Yorkers living with epilepsy and raises awareness for the condition.

NY Health Launches Statewide Anti-Vaping Campaign for Youth

The New York State Department of Health has launched a statewide anti-vaping public awareness campaign targeting teens, young adults, and parents. The initiative, running through April 26, 2026, aims to educate on vaping risks and promote the 'DropTheVape' text support program for quitting nicotine products.

Intranasal Pharmaceutical Composition for Migraine Treatment

The USPTO has published a patent application (US20260083693A1) for an intranasal pharmaceutical composition containing ibuprofen and ketoprofen for treating migraine and headaches. The application details a method for manufacturing preparations with a combination of these active ingredients at reduced dosages compared to oral administration.

Patent Application: Methods Treat/Prevent Protein Aggregation Diseases Using Sulfatase Inhibitor

The USPTO has published a new patent application (US20260083700A1) detailing methods for treating and/or preventing protein-aggregation diseases by administering a sulfatase inhibitor. The application was filed on September 26, 2025, by inventors Manuel J. Muñoz, Ángel M. Carrión, and Mercedes M. Pérez-Jiménez.

Patent Application for Suppressing Reflux-Induced Protein Adducts

The USPTO has published patent application US20260083686A1, filed on November 24, 2025, by Alexander Zaika and Sergey I Dikalov. The application details methods and compounds for suppressing the accumulation of reflux-induced protein adducts.

USPTO Patent Application for Lactation Reduction Compounds

The USPTO has published a patent application (US20260083687A1) for compounds intended for reducing lactation and improving health. The application, filed on April 14, 2023, lists specific disulfide, sulfide, trisulfide, sulfone, thiosulfinate, and thiosulfonate compounds as preferred embodiments. This represents a new patent filing, not a regulatory rule or guidance.

Skin Barrier Film System Patent Application

The USPTO has published a new patent application, US20260083684A1, for a skin barrier film system. The application details a system comprising a film layer, adhesive, impregnated treatment, and a removable layer, designed to accommodate patient physical attributes. The filing date was September 24, 2025.

Method Uses Monoterpene or Sesquiterpene to Permeabilize Blood Brain Barrier

The USPTO has published a patent application detailing a method for permeabilizing the blood-brain barrier using monoterpenes or sesquiterpenes. The application, assigned to the University of Southern California, describes a treatment for central nervous system cancers involving perillyl alcohol and CAR-T cells.

NACA Tablets Inhibit Vision Reduction in Usher Syndrome Patients

The USPTO has published a patent application (US20260083688A1) detailing compositions and methods for treating Usher syndrome associated retinitis pigmentosa using N-acetylcysteine amide (NACA) tablets. The application outlines specific dosages and claims to inhibit vision degradation and protect retinal sensitivity in patients.

Patent Application: Reversing Dexmedetomidine Sedation

The USPTO has published a patent application (US20260083689A1) detailing methods and compositions for reversing dexmedetomidine sedation using dextroamphetamine and/or lisdexamfetamine. The application was filed on October 7, 2025, by inventors Ken Solt, Oluwaseun Johnson-Akeju, and Emery N. Brown.

Patent Application for Dispersible Pharmaceutical Formulations

The USPTO has published patent application US20260083690A1 concerning dispersible pharmaceutical formulations of a specific chemical compound. The application details the composition and potential uses of these formulations.

Patent Application: Composition for Controlling Aquatic Organism Infections

The USPTO has published a new patent application (US20260083697A1) from B. G. Negev Technologies and Applications Ltd. The application details a composition containing an esterified fatty acid for preventing or treating monogenean infections in aquatic organisms.

Patent Application: Synergistic Stimulation for Cystic Fibrosis Mucus Obstruction

The USPTO has published a new patent application (US20260083698A1) detailing methods for treating mucus obstruction in cystic fibrosis and other disorders. The application, filed on September 19, 2023, describes a combination therapy involving a b-adrenergic agonist or adenylate cyclase activator with a cholinergic agonist.

Patent Application for Psychoactive Medicines Treating Disorders

The USPTO has published patent application US20260083699A1 by Transcend Therapeutics, Inc. The application details psychoactive medicines, including 2C-B and cathinones, for treating psychiatric and neurological conditions. The filing date was December 4, 2025.

Patent Application for Inflammatory Condition Treatment Compositions

The USPTO has published a new patent application (US20260083701A1) for compositions and methods related to the treatment of inflammatory conditions. The application details compounds and formulations aimed at managing inflammation and associated symptoms like dryness, itching, and redness.

Patent Application: Inhalation Formulation for Treating IPF Disease

The USPTO has published a patent application (US20260083702A1) detailing an inhalation formulation for treating Idiopathic Pulmonary Fibrosis (IPF) disease. The application describes formulations using specific drugs like apremilast and roflumilast, aiming to improve bioavailability and clinical efficacy compared to oral administration.

USPTO Patent Application for Indoline Derivatives as Serotonergic Agents

The USPTO has published a patent application (US20260083703A1) for indoline derivatives intended for use as serotonergic agents. The application details potential treatments for disorders related to serotonin receptor activation, including psychosis, mental illnesses, and CNS disorders.

Gamma-hydroxybutyrate Formulations with Improved Pharmacokinetics

The USPTO has published a new patent application, US20260083696A1, detailing modified release formulations of gamma-hydroxybutyrate with improved dissolution and pharmacokinetic properties. The application was filed on October 1, 2025, by inventors Jordan Dubow, Claire Megret, Hervé Guillard, and Jean-François Dubuisson.

Patent Application: Composition for Mitigating Veisalgia and Nausea

The USPTO has published a patent application (US20260083695A1) for a composition designed to reduce veisalgia (hangover) symptoms and nausea. The application details an orally deliverable formulation containing dihydromyricetin, acetylcysteine, and specific antiemetics, with a filing date of September 10, 2025.

Composition of L-leucine and fish oil for muscle health

The USPTO has published a patent application (US20260083694A1) for a composition comprising L-leucine and fish oil, intended for muscle health and the prevention of muscle mass and strength loss. The application was filed by ABIOGEN PHARMA S.P.A.

Patent Application for Treating Disease with Dichlorphenamide

The USPTO has published a patent application (US20260083692A1) from Strongbridge Dublin Limited for methods of treating disease using dichlorphenamide in conjunction with an organic anion transporter-1 (OAT1) substrate. The application details methods for administering the compounds and monitoring patient response and toxicity.

Tennessee Rural Health Transformation Program Funding Info Session

The Tennessee Department of Health is hosting an information session on March 31, 2026, to detail funding opportunities for the Tennessee Rural Health Transformation Program (RHTP). This follows Tennessee's award of over $206 million in federal funding for rural health initiatives.

Flexible Ultrasound Transducer Patent Grant US12585014B2

The USPTO has granted patent US12585014B2 for a flexible ultrasound transducer and an associated shape estimation method. The patent, assigned to KATHOLIEKE UNIVERSITEIT LEUVEN, details a system for determining the actual shape of flexible ultrasound devices.

Patent Grant: Minimally Invasive Histotripsy Systems and Methods

The USPTO has granted a patent (US12582848B2) to The Regents of the University of Michigan for minimally invasive histotripsy systems and methods. The patent covers devices insertable endoscopically or laparoscopically for targeted tissue therapy.

Ultrasonic Diagnostic Apparatus Patent Granted to FUJIFILM Corporation

The USPTO has granted patent US12587845B2 to FUJIFILM Corporation for an ultrasonic diagnostic apparatus. The patent covers technology related to wireless communication and group ID selection for establishing secure connections with information terminals.

Patent Grant for In Vivo Radiation Dosimetry Tool

The USPTO has granted a patent (US12582846B2) to The Regents of the University of California for an in vivo radiation dosimetry tool. This tool utilizes X-ray-induced acoustic computed tomography (XACT) to measure absolute radiation dose delivered during radiotherapy, aiming to improve precision and patient outcomes in cancer treatment.

Tendon repair implant and surgical instruments disclosed

The USPTO has granted a patent (US12582514B2) for a tendon repair implant and related surgical instruments. The patent, assigned to Ketonis Innovations LLC, details an implant with spikes for optimal tendon retention and associated surgical tools for precise placement.

Patent US12582513B2: Tool kit for tendon fixation implant

The USPTO has granted patent US12582513B2 for a tool kit designed for the minimally invasive implantation of tendon fixation implants in arthroscopic human medicine. The patent, assigned to INOVEDIS GmbH, details specific inserters and components for medical procedures.

USPTO Patent Grant for Omni-Abutment Core and Methods

The USPTO has granted patent US12582508B2 for an omni-abutment core and methods of use, assigned to ESTHETIC IMPLANT SOLUTIONS, LLC. This patent introduces novel features for dental abutments aimed at simplifying the restorative process and fabrication of dental prostheses.

Patent Grant for Surgical Field Data Visualization

The USPTO has granted patent US12582499B1 to Integro Theranostics, LLC for a system and method for visualizing fluorescing tissue in a surgical field. The patent covers technology that aids in identifying and displaying adjacent fluorescing tissue outside the immediate camera view.

Patent Grant for Surgical Video Stream Processing

The USPTO has granted patent US12582498B2 for a device that processes video streams from surgical operations. The patent, filed on June 11, 2021, describes a system for determining the progress of surgical steps based on image analysis.